Herman Verrelst

We are on a mission to help patients by improving the quality, safety and accessibility of nuclear imaging. ​ Our software solutions will assist the physician along the entire workflow, from image acquisition to diagnosis and follow-up.​

We provide cloud-based software for spatial multi-omics data management and analysis. We are specialized in accurate spatial co-registration across tissue sections and integrating data across fundamentally different assays, including mass spectrometry imaging, spatial transcriptomics, multiplexed fluorescence microscopy and traditional histology. In addition to our software portfolio, we provide access to a team of world-class bioinformaticians that can help our collaborators with challenging bioinformatics research, including new applications, technology integrations, and high-end in-depth analysis.

FOx Biosystems aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology. The FOx technology is based on an innovative fiber-optic-based surface plasmon resonance biosensor technology. This enables the users to generate high quality biomolecular data such as affinity data, kinetic data and concentration measurements. FOx biosensor technology has several benefits compared to existing biomolecular analysis tools, including ease of use, speed, wide applicability and cost-effectiveness. FOx Biosystems sells instruments, reagents and services to improve biomolecular interaction analysis in life science research and industry. FOx Biosystems was founded in 2016 as a spin-off of the KU Leuven and still closely collaborates with the university for further innovations.

UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors. FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder’s modules include Analysis, Genotyper and Workflow.

Transforming patient care through imaging AI. Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence. icometrix offers a portfolio of AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimers disease. icompanion, a digital platform, and the mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively. icolung addresses the COVID-19 pandemic by measuring lung involvement on chest CT. Today, icometrix is internationally active and integrated into more than 300 clinical practices. In addition, icometrix collaborates with healthcare providers and pharmaceutical companies on the evaluation of drug research for neurological disorders.

We are on a mission to help patients by improving the quality, safety and accessibility of nuclear imaging. ​ Our software solutions will assist the physician along the entire workflow, from image acquisition to diagnosis and follow-up.​

We provide cloud-based software for spatial multi-omics data management and analysis. We are specialized in accurate spatial co-registration across tissue sections and integrating data across fundamentally different assays, including mass spectrometry imaging, spatial transcriptomics, multiplexed fluorescence microscopy and traditional histology. In addition to our software portfolio, we provide access to a team of world-class bioinformaticians that can help our collaborators with challenging bioinformatics research, including new applications, technology integrations, and high-end in-depth analysis.

HERAN PARTNERS is a Belgian-based investment fund founded by Annie Vereecken together with Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst within the sector of MedTech and Digital Health. With a clear focus on European HealthTech, the fund provides venture & growth capital accompanied by a strong network, expertise and mentorship to startups and scale-ups with a strong technology platform and market potential. We strive to have impact! 

FOx Biosystems aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology. The FOx technology is based on an innovative fiber-optic-based surface plasmon resonance biosensor technology. This enables the users to generate high quality biomolecular data such as affinity data, kinetic data and concentration measurements. FOx biosensor technology has several benefits compared to existing biomolecular analysis tools, including ease of use, speed, wide applicability and cost-effectiveness. FOx Biosystems sells instruments, reagents and services to improve biomolecular interaction analysis in life science research and industry. FOx Biosystems was founded in 2016 as a spin-off of the KU Leuven and still closely collaborates with the university for further innovations.

flanders.bio is the cluster organisation empowering a life sciences driven network economy. We help our members to create value by organising networking and training activities, supporting internationalisation, providing services and building expertise.